Lung cancer screening: Has there been any progress? Computed tomography and autofluorescence bronchoscopy

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 4, 2007, Pages 243-248

  Lee, Pyng ^a   Sutedja, Tom G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autofluorescence bronchoscopy; CT; Lung cancer; PET; Screening

Indexed keywords

AUTOFLUORESCENCE BRONCHOSCOPY; BRONCHOSCOPY; BUDGET; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; EARLY CANCER; EARLY DIAGNOSIS; FLUORESCENCE; HEALTH CARE COST; HUMAN; INVASIVE PROCEDURE; LUNG CANCER; LUNG NODULE; LUNG PARENCHYMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PUBLICATION; QUALITY OF LIFE; REVIEW; SCREENING TEST; SMOKING;

BRONCHOSCOPY; FLUORESCENCE; HUMANS; LUNG NEOPLASMS; MASS SCREENING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249796387     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32818b27d3     Document Type: Review

References (50)

1. Lynch TJ, Adjei AA, Bunn PA Jr, et al. Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents. Clin Cancer Res 2006; 12:4365s-4371s.
2. Peltola H, Karanko V, Kurki T, et al. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet 1986; 1:137-139.
3. Black WC. Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests. J Clin Oncol 2006; 24:3252-3260. This is an interesting review on important issues related to screening with sensitive imaging tests.
4. Jett JR. Limitations of screening for lung cancer with low-dose spiral computed tomography. Clin Cancer Res 2005; 11:4988s-4992s.
5. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med 2005; 352:2714-2720.
6. Pastorino U. Early detection of lung cancer. Respiration 2006; 73:5-13. This is is a comprehensive up to date review on early detection of lung cancer with CT and PET.
7. Schoder H, Gonen M. Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med 2007; 48 (Suppl 1):4S-18S.
8. Strauss GM, Dominioni L. Perception, paradox, paradigm: Alice in the wonderland of lung cancer prevention and early detection. Cancer 2000; 89:2422-2431.
9. Marcus PM, Bergstralh EJ, Zweig MH, et al. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006; 98:748-756.
10. Black C, de Verteuil R, Walker S, et al. Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature. Thorax 2007; 62:131-138.
11. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA 2007; 297:953-961. The authors put lung cancer screening in perspective.
12. rd ed. Berlin: Springer-Verlag; 1999.
13. Pasic A, Postmus PE, Sutedja TG. What is early lung cancer? A review of the literature. Lung Cancer 2004; 45:267-277.
14. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage nonsmall-cell lung cancer. N Engl J Med 2006; 355:570-580. This presents ground-breaking data on genetic profiling to better prognosticate individuals with stage 1A lung cancers likely to relapse and benefit from adjuvant chemotherapy.
15. Lu Y, Lemon W, Liu PY, et al. A gene expression signature predicts survival of patients with stage I nonsmall cell lung cancer. PLoS Med 2006; 3:e467.
16. Diederich S, Wormanns D, Semik M, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002; 222:773-781.
17. McWilliams A, Mayo J, MacDonald S, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003; 168:1167-1173.
18. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165:508-513.
19. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362:593-597.
20. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395-400.
21. Swensen SJ. CT screening for lung cancer. AJR Am J Roentgenol 2002; 179:833-836.
22. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004; 231:164-168.
23. Midthun DE. Solitary pulmonary nodule: time to think small. Curr Opin Pulm Med 2000; 6:364-370.
24. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001; 92:153-159.
25. Bruzzi JF, Munden RF. PET/CT imaging of lung cancer. J Thorac Imaging 2006; 21:123-136.
26. Goodman LR, Gulsun M, Washington L, et al. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. AJR Am J Roentgenol 2006; 186:989-994.
27. Truong MT, Pan T, Erasmus JJ. Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging. J Thorac Imaging 2006; 21:111-122.
28. Flieder DB, Vazquez M, Carter D, et al. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 2006; 30:606-613.
29. Thunnissen FB, Kerr KM, Brambilla E, et al. EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer. Eur Respir J 2006; 28:1186-1189.
30. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 2005; 11:537-543.
31. Gohagan JK, Marcus PM, Fagerstrom RM, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005; 47:9-15.
32. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355:1763-1771.
33. Gould MK, Berg CD, Aberle DR, et al. CT Screening for lung cancer. N Engl J Med 2007; 356:743-747.
34. Vierikko T, Jarvenpaa R, Autti T, et al. Chest CT screening of asbestosexposed workers: lung lesions and incidental findings. Eur Respir J 2007; 29:78-84.
35. Das M, Muhlenbruch G, Mahnken AH, et al. Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector-row CT. Eur Radiol 2006; Sep 20 [Epub ahead of print].
36. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multislice CT screening trial (NELSON). Int J Cancer 2007; 120:868-874.
37. Prosch H, Strasser G, Oschatz E, et al. Management of patients with small pulmonary nodules: a survey of radiologists, pulmonologists, and thoracic surgeons. AJR Am J Roentgenol 2006; 187:143-148.
38. Silvestri GA, Nietert PJ, Zoller J, et al. Attitudes towards screening for lung cancer among smokers and their nonsmoking counterparts. Thorax 2007; 62:126-130. This provides revealing data on the attitudes of smokers concerning CT screening for early detection of lung cancer, compliance and treatment.
39. Mahadevia PJ, Fleisher LA, Frick KD, et al. Lung cancer screening with helical computed tomography in older adult smokers: a decision and costeffectiveness analysis. JAMA 2003; 289:313-322.
40. Loewen G, Natarajan N, Tan D, et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2006; 62:335-340.
41. George PJ. Fluorescence bronchoscopy for the early detection of lung cancer. Thorax 1999; 54:180-183.
42. Pasic A, Vonk-Noordegraaf A, Risse EK, et al. Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients. Lung Cancer 2003; 41:295-301.
43. Helfritzsch H, Junker K, Bartel M, Scheele J. Differentiation of positive autofluorescence bronchoscopy findings by comparative genomic hybridization. Oncol Rep 2002; 9:697-701.
44. Pasic A, Brokx HA, Vonk NA, et al. Cost-effectiveness of early intervention: comparison between intraluminal bronchoscopic treatment and surgical resection for T1N0 lung cancer patients. Respiration 2004; 71:391-396.
45. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833-4839.
46. Sutedja TG, Codrington H, Risse EK, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest 2001; 120:1327-1332.
47. Vonk-Noordegraaf A, Postmus PE, Sutedja TG. Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. Lung Cancer 2003; 39:49-53.
48. Lebeau B. Medical ethics and therapeutic progress: the example of lung cancer. Hippocrates to the rescue! Lung Cancer 2000; 30:9-13.
49. Fang CT, Chang YY, Hsu HM, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. Q J Med 2007; 100:97-105.
50. Henry SG, Zaner RM, Dittus RS. Viewpoint: moving beyond evidence-based medicine. Acad Med 2007; 82:292-297.